These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 22789927

  • 1. Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.
    Taylor AC, Mendel TA, Mason KE, Degen KE, Yates PA, Peirce SM.
    Invest Ophthalmol Vis Sci; 2012 Aug 13; 53(9):5462-70. PubMed ID: 22789927
    [Abstract] [Full Text] [Related]

  • 2. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun 13; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 3. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E, Li X, He S, Li X, He S.
    Mol Biol Rep; 2020 Jun 13; 47(6):4681-4690. PubMed ID: 32488576
    [Abstract] [Full Text] [Related]

  • 4. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
    Davies MH, Stempel AJ, Hubert KE, Powers MR.
    Dev Dyn; 2010 Jun 13; 239(6):1695-707. PubMed ID: 20503366
    [Abstract] [Full Text] [Related]

  • 5. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
    Gong T, Xu J, Heng B, Qiu S, Yi B, Han Y, Lo ECM, Zhang C.
    J Dent Res; 2019 Jul 13; 98(7):803-812. PubMed ID: 31017515
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C, Martin G, Lange C, Gogaki EG, Fiedler U, Schaffner F, Hansen LL, Augustin HG, Agostini HT.
    Acta Ophthalmol; 2011 Feb 13; 89(1):82-90. PubMed ID: 19764912
    [Abstract] [Full Text] [Related]

  • 7. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.
    J Cell Sci; 2003 Jun 15; 116(Pt 12):2461-70. PubMed ID: 12734395
    [Abstract] [Full Text] [Related]

  • 8. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.
    Kida Y, Ieronimakis N, Schrimpf C, Reyes M, Duffield JS.
    J Am Soc Nephrol; 2013 Mar 15; 24(4):559-72. PubMed ID: 23492730
    [Abstract] [Full Text] [Related]

  • 9. Effect of EphB4/EphrinB2 reverse signal on angiogenesis induced by Xuefu Zhuyu Capsule () containing serum in human microvascular endothelial cell 1.
    Zhang JS, Wang YZ, Hu YQ, Lin F, Gao D, Song J, Kaptchuk TJ, Chen KJ.
    Chin J Integr Med; 2016 Aug 15; 22(8):605-10. PubMed ID: 27299459
    [Abstract] [Full Text] [Related]

  • 10. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E, Brkic S, Uccelli A, Wirth G, Korpisalo-Pirinen P, Filippova M, Dasen B, Sacchi V, Muraro MG, Trani M, Reginato S, Gianni-Barrera R, Ylä-Herttuala S, Banfi A.
    EMBO Rep; 2018 May 15; 19(5):. PubMed ID: 29643120
    [Abstract] [Full Text] [Related]

  • 11. Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.
    Davies MH, Zamora DO, Smith JR, Powers MR.
    Microvasc Res; 2009 May 15; 77(3):382-6. PubMed ID: 19232363
    [Abstract] [Full Text] [Related]

  • 12. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.
    Invest Ophthalmol Vis Sci; 2006 May 15; 47(5):2125-34. PubMed ID: 16639024
    [Abstract] [Full Text] [Related]

  • 13. Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis.
    Yuan K, Hong TM, Chen JJ, Tsai WH, Lin MT.
    Blood; 2004 Aug 15; 104(4):1025-33. PubMed ID: 15126321
    [Abstract] [Full Text] [Related]

  • 14. EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease.
    Yang D, Jin C, Ma H, Huang M, Shi GP, Wang J, Xiang M.
    Angiogenesis; 2016 Jul 15; 19(3):297-309. PubMed ID: 27216867
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice.
    Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N.
    Dev Biol; 2008 Mar 01; 315(1):72-88. PubMed ID: 18206868
    [Abstract] [Full Text] [Related]

  • 16. Modulation of hypoxia-induced neovascularization by JSM6427, an integrin alpha5beta1 inhibiting molecule.
    Maier AK, Kociok N, Zahn G, Vossmeyer D, Stragies R, Muether PS, Joussen AM.
    Curr Eye Res; 2007 Sep 01; 32(9):801-12. PubMed ID: 17882713
    [Abstract] [Full Text] [Related]

  • 17. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
    Umeda N, Ozaki H, Hayashi H, Oshima K.
    Am J Ophthalmol; 2004 Aug 01; 138(2):270-9. PubMed ID: 15289137
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
    Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW.
    Am J Pathol; 2005 Feb 01; 166(2):637-44. PubMed ID: 15681845
    [Abstract] [Full Text] [Related]

  • 19. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H, Fukushima Y, Maruyama K, Hirashima M, Nishida K, Nishikawa S, Uemura A.
    Invest Ophthalmol Vis Sci; 2013 Jun 12; 54(6):4102-8. PubMed ID: 23696610
    [Abstract] [Full Text] [Related]

  • 20. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
    Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P.
    EMBO J; 2006 Feb 08; 25(3):628-41. PubMed ID: 16424904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.